Funded Startups in Baltimore
In the 50 most recent Baltimore-funded rounds shown, the largest disclosed amount is Dominion Financial Services’ $150M (2025-04-07).
In the 50 most recent Baltimore-funded rounds shown, the largest disclosed amount is Dominion Financial Services’ $150M (2025-04-07). That figure dwarfs the rest of the disclosed rounds clustered largely below ~$40M—for example Delfi Diagnostics’ $34M (2025-12-18), Rapafusyn Pharmaceuticals’ $28M (2024-06-20), and Facet’s $25M (2024-10-08). Sector clustering is visible in both geography and industry: Biotechnology appears repeatedly across the list (e.g., Pearl Diagnostics $11M on 2026-04-02; Delfi Diagnostics $34M on 2025-12-18; Sonavex $15M on 2024-10-24), while Health Care is also frequent (e.g., CraniUS $1M on 2026-06-29; Forte $3M on 2023-12-19). Temporally, the dataset spans from 2023-10-10 (Hungry Harvest) to 2026-06-29 (CraniUS), with many entries landing between 2024-10 and 2025-06. Disclosed-stage information is sparse: 33 of 50 entries are labeled “Series Unknown,” and 9 entries list “undisclosed” amounts.
Most recent rounds
50 of 12474 more funded startups
This page shows the 50 most recent rounds (back to Oct 2023). The full 124-company history for this listing is available on a paid plan.
Unlock all 124 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
Which round size is the clear outlier in this Baltimore list, and how far above the next tier does it sit?
Dominion Financial Services’ $150M (2025-04-07) is the only disclosed round in this list that reaches the triple-digit range. The next-highest disclosed amounts include $51M (Capital Funding Group, 2025-04-01) and $34M (Delfi Diagnostics, 2025-12-18), making the $150M figure stand out from the rest of the disclosed distribution.
Do the most recent entries cluster in a tight date window, or are they evenly spread?
The rounds are concentrated in the middle of the timeline rather than evenly distributed: several sizeable deals appear in 2024-10 through 2025-06, including Sunairio $6M (2024-12-20), Qualytics $10M (2025-06-23), and Delfi Diagnostics $34M (2025-12-18). The date range itself runs from 2023-10-10 (Hungry Harvest) to 2026-06-29 (CraniUS), indicating coverage of multiple cycles, not a single quarter.
How dominant is “Series Unknown,” and what does that imply for comparing stages across Baltimore rounds?
Stage labeling is heavily incomplete: 33 of 50 entries are “Series Unknown,” and 9 entries have “undisclosed” amounts. Even among the few explicitly staged rounds, examples like Qualytics (Series A, $10M on 2025-06-23) and SereNeuro Therapeutics (Series Unknown with undisclosed amount on 2026-05-01) highlight that stage comparisons will be uneven without disclosed series and amounts.
Are there sector concentrations worth prioritizing for outreach (or diligence) in Baltimore?
Biotechnology shows up frequently across years, including Pearl Diagnostics (2026-04-02, $11M), Delfi Diagnostics (2025-12-18, $34M), and Sonavex (2024-10-24, $15M). Health Care is also present across multiple waves, such as CraniUS (2026-06-29, $1M) and Forte (2023-12-19, $3M), suggesting repeated deal flow rather than a single isolated theme.
Which industries pair with the largest disclosed checks in this list?
The highest disclosed amounts are tied to financial services and life sciences rather than consumer-only categories: Dominion Financial Services has $150M (2025-04-07), Capital Funding Group has $51M (2025-04-01), and Delfi Diagnostics has $34M (2025-12-18). On the biotech side, other large checks include Rapafusyn Pharmaceuticals’ $28M (2024-06-20), while many smaller entries in the 2026 window are at $1M–$2M levels (e.g., CraniUS $1M on 2026-06-29; Synaptic $2M on 2026-05-08).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.